HealthEquity未能公布第四季度财报，但提升了2026年展望，股价接近52周高点。 HealthEquity missed Q4 earnings but raised 2026 outlook, stock near 52-week high.

据报道,HealthEquity第四季度的收益为每股0.82美元,低于0.90美元的共识,并更新了其2026财年指导,每股收益预计在3.87美元至3.95美元之间,高于预期,收入为13亿美元,符合预测. HealthEquity reported fourth-quarter earnings of $0.82 per share, missing the $0.90 consensus, and updated its fiscal 2026 guidance with EPS expected between $3.87 and $3.95, above estimates, and revenue of $1.3 billion, in line with forecasts. 2025年10月8日,该库存以98.64美元关闭,52周范围为74.07美元至116.65美元。 The stock closed at $98.64 on October 8, 2025, with a 52-week range of $74.07 to $116.65. 尽管收入略有下降,分析师仍维持“机动购买”评级,目标为119.00美元。 Despite a slight dip in earnings, analysts maintain a "Moderate Buy" rating with a $119.00 target. 内部投资者出售了大约102万美元的股票,将所有权减少到1.50%,而机构投资者持有99.55%的股份。 Insiders sold about $1.02 million in shares, reducing their ownership to 1.50%, while institutional investors hold 99.55%. 该公司为美国消费者和雇主经营云型健康储蓄账户平台。 The company operates cloud-based health savings account platforms for U.S. consumers and employers.